| Issue |
BIO Web Conf.
Volume 192, 2025
6th International Conference on Smart and Innovative Agriculture (ICoSIA 2025)
|
|
|---|---|---|
| Article Number | 06005 | |
| Number of page(s) | 7 | |
| Section | Plant and Animal Biotechnology | |
| DOI | https://doi.org/10.1051/bioconf/202519206005 | |
| Published online | 24 October 2025 | |
Plant-Based Production and Purification of Functional Anti-CD3 Antibody Using Agrobacterium-Mediated Expression
Department of Pharmocognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Science, Chulalongkorn University, Bangkok 10330 Thailand
* Corresponding author: 6770032633@student.chula.ac.th
The murine monoclonal antibody OKT3, which targets the CD3 complex on T cells, was the first FDA-approved therapeutic antibody and remains clinically relevant for reversing acute transplant rejection. However, conventional mammalian production systems for monoclonal antibodies are expensive, time-consuming, and prone to contamination. In this study, we investigated the feasibility of using Nicotiana benthamiana as a cost-effective and scalable plant-based platform for transient expression and purification of functional OKT3 antibody. Codon-optimized sequences for the heavy and light chains of OKT3 were designed with signal peptides for ER targeting and a C-terminal SEKDEL sequence to enhance protein folding and retention. These sequences were cloned into a geminiviral vector and transformed into Agrobacterium tumefaciens, followed by co-infiltration into N. benthamiana leaves. Western blot analysis confirmed successful expression and assembly of the antibody. Purification was performed using Protein A affinity chromatography. Functional analysis by flow cytometry demonstrated that the FITC-conjugated plant-produced OKT3 antibody exhibited slightly higher CD3+ T cell binding efficiency and stronger fluorescence intensity than the commercial APC-conjugated counterpart. These findings support the use of N. benthamiana as a viable platform for functional anti-CD3 antibody production, with potential applications in diagnostics and therapeutics.
© The Authors, published by EDP Sciences, 2025
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.

